keyword
https://read.qxmd.com/read/38606145/real-world-experience-quantifying-access-to-jak-inhibitor-care-for-alopecia-areata-patients-a-patient-centered-survey-study
#1
JOURNAL ARTICLE
Ambika Nohria, Ya-Han Crystal Zhang, Deesha Desai, Alison Lee, Lisa Anderson, Jerry Shapiro, Maryanne Senna, Kristen Lo Sicco
BACKGROUND: Janus kinase inhibitor (JAKi) therapy has revolutionized the treatment landscape for alopecia areata (AA); however, access may be limited by a lack of insurance coverage and high out-of-pocket costs. OBJECTIVE: We aimed to evaluate real-world patient experiences regarding access to JAKi therapy. METHODS: We conducted an online patient-centered survey using the National Alopecia Areata Foundation listserv. RESULTS: In total 784 individuals initiated our survey, and 600 completed it in full (76...
June 2024: International Journal of Women's Dermatology
https://read.qxmd.com/read/38573268/national-trends-in-hospital-performance%C3%A2-in-guideline-recommended-pharmacologic-treatment-for-heart%C3%A2-failure-at-discharge
#2
JOURNAL ARTICLE
Paul L Hess, Paula Langner, Paul A Heidenreich, Utibe Essien, Chelsea Leonard, Stanley A Swat, Vincenzo Polsinelli, Steven T Orlando, Gary K Grunwald, P Michael Ho
BACKGROUND: The use of recommended heart failure (HF) medications has improved over time, but opportunities for improvement persist among women and at rural hospitals. OBJECTIVES: This study aims to characterize national trends in performance in the use of guideline-recommended pharmacologic treatment for HF at U.S. Department of Veterans Affairs (VA) hospitals, at which medication copayments are modest. METHODS: Among patients discharged from VA hospitals with HF between January 1, 2013, and December 31, 2019, receipt of all guideline-recommended HF pharmacotherapy among eligible patients was assessed, consisting of evidence-based beta-blockers; angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, or angiotensin receptor neprilysin inhibitors; mineralocorticoid receptor antagonists; and oral anticoagulation...
March 23, 2024: JACC. Heart Failure
https://read.qxmd.com/read/38556686/out-of-pocket-costs-and-payments-in-autologous-and-implant-based-breast-reconstruction-a-nationwide-analysis
#3
JOURNAL ARTICLE
Olachi O Oleru, Nargiz Seyidova, Peter J Taub, Christine H Rohde
BACKGROUND: Many factors influence a patient's decision to undergo autologous versus implant-based breast reconstruction, including medical, social, and financial considerations. This study aims to investigate differences in out-of-pocket and total spending for patients undergoing autologous and implant-based breast reconstruction. METHODS: The IBM MarketScan Commercial Databases were queried to extract all patients who underwent inpatient autologous or implant-based breast reconstruction from 2017 to 2021...
April 1, 2024: Annals of Plastic Surgery
https://read.qxmd.com/read/38554624/healthcare-utilization-in-women-diagnosed-with-endometrial-cancer-a-survey-based-study
#4
JOURNAL ARTICLE
Nerlyne Desravines, Dana Hazimeh, Michael R Desjardins, Stephanie L Wethington
OBJECTIVE: Despite similar incidence, non-Hispanic Black women are twice as likely to die of endometrial cancer as non-Hispanic White women. The social determinants of health may contribute to this disparity. We studied barriers to care and social needs of endometrial cancer patients. METHODS: In a cohort of patients with endometrial cancer from the All of Us study, participants self-reported demographics and completed validated surveys (access to medical care, transportation, caregiving, finances, medication, general care, specialty care, housing insecurity)...
March 29, 2024: Gynecologic Oncology
https://read.qxmd.com/read/38536824/copayment-mechanism-in-selected-districts-of-uganda-availability-market-share-and-price-of-quality-assured-artemisinin-based-combination-therapies-in-private-drug-outlets
#5
JOURNAL ARTICLE
Moses Ocan, Winnie Nambatya, Caroline Otike, Loyce Nakalembe, Sam Nsobya
BACKGROUND: Malaria remains one of the leading causes of morbidity, and mortality in Uganda. A large proportion of malaria symptomatic patients seek healthcare in private sector. However, availability and affordability are major barriers to access to effective treatment. The private sector copayment mechanism in Uganda aims to increase availability and affordability of antimalarial agents. Our study assessed availability, price, and market share of quality assured artemisinin-based combination therapies (QAACTs) in private drug outlets in selected districts during the implementation of copayment mechanism...
2024: PloS One
https://read.qxmd.com/read/38520502/real-world-adherence-to-and-persistence-with-vibegron-in-patients-with-overactive-bladder-a-retrospective-claims-analysis
#6
JOURNAL ARTICLE
Benjamin Chastek, Adam Carrera, Christina Landis, Daniel Snyder, Laleh Abedinzadeh, Tim Bancroft, Jeffrey Nesheim, Michael Kennelly, David Staskin
INTRODUCTION: Vibegron is a β3 -adrenergic receptor agonist approved for overactive bladder (OAB). This analysis assessed real-world adherence and persistence with vibegron in patients with OAB, along with demographics and clinical characteristics associated with adherence and persistence. METHODS: This retrospective study used the Optum Research Database to identify patients treated with vibegron from April 2021 to August 2022 (identification period). Patients had ≥ 60 days of continuous pharmacy coverage in a commercial or Medicare Advantage plan following the index fill (follow-up)...
March 23, 2024: Advances in Therapy
https://read.qxmd.com/read/38502072/copay
#7
JOURNAL ARTICLE
Ayelet Amittay
No abstract text is available yet for this article.
March 19, 2024: JAMA
https://read.qxmd.com/read/38477051/in-house-molecular-diagnosis-of-diffuse-glioma-updating-the-revised-who-classification-by-a-platform-of-the-advanced-medical-care-system-senshin-iryo
#8
JOURNAL ARTICLE
Nobuhiro Hata, Yutaka Fujioka, Ryosuke Otsuji, Daisuke Kuga, Ryusuke Hatae, Yuhei Sangatsuda, Takeo Amemiya, Naoki Noguchi, Aki Sako, Minoru Fujiki, Masahiro Mizoguchi, Koji Yoshimoto
Since the World Health Organization (WHO) 2016 revision, the number of molecular markers required for diffuse gliomas has increased, placing a burden on clinical practice. We have established an in-house, molecular diagnostic platform using Senshin-Iryo, a feature of Japan's unique healthcare system, and partially modified the analysis method in accordance with the WHO 2021 revision. Herein, we review over a total 5 years of achievements using this platform. Analyses of IDH, BRAF, and H3 point mutations, loss of heterozygosity (LOH) on 1p/19q and chromosomes 10 and 17, and MGMT methylation were combined into a set that was submitted to Senshin-Iryo as "Drug resistance gene testing for anticancer chemotherapy" and was approved in August 2018...
March 13, 2024: Neuropathology: Official Journal of the Japanese Society of Neuropathology
https://read.qxmd.com/read/38469165/a-retrospective-observational-study-on-telemedicine-in-prescribing-low-dose-pills-for-patients-with-dysmenorrhea
#9
JOURNAL ARTICLE
Yumi Inoo, Hiroshi Iida, Norihito Yoshioka, Hideki Koyama, Yusuke Saigusa, Kentaro Kurasawa, Masahiko Inamori
INTRODUCTION: In Japan, telemedicine has gradually expanded due to deregulation in response to the COVID-19 pandemic. However, its current status remains unclear, as it is primarily provided by general practitioners. Meanwhile, telemedicine has begun to be utilized for low-dose estrogen-progestin (LEP) prescriptions for dysmenorrhea. METHODS: We conducted a retrospective analysis of medical record data from two gynecology clinics and performed an exploratory evaluation between a group that combined telemedicine and in-person visits during the initial 6 months of LEP treatment, and another group with only in-person visits...
2024: Telemedicine reports
https://read.qxmd.com/read/38432284/out-of-pocket-cost-modeling-of-adjuvant-antiestrogen-and-radiation-therapy-after-lumpectomy-for-early-stage-breast-cancer-across-medicaid-and-medicare-plans
#10
JOURNAL ARTICLE
Victoria S Wu, Martha Khlopin, Manjeet Chadha, Demetria J Smith-Graziani, Reshma Jagsi, Shearwood McClelland
PURPOSE: The optimal adjuvant therapy (anti-estrogen therapy (ET) + radiotherapy or ET alone, or in some reports radiotherapy alone) in older women with early-stage breast cancer has been highly debated. However, granular details on the role of insurance in the out-of-pocket cost for patients receiving ET with or without radiotherapy are lacking. This project disaggregates out-of-pocket costs by insurance plans to increase treatment cost transparency. METHODS AND MATERIALS: Several radiotherapy schedules are accepted standards as per the National Comprehensive Cancer Network guidelines...
March 1, 2024: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/38428266/effects-of-nurse-visit-copayment-on-primary-care-use-do-low-income-households-pay-the-price
#11
JOURNAL ARTICLE
Tapio Haaga, Petri Böckerman, Mika Kortelainen, Janne Tukiainen
Nurses are increasingly providing primary care, yet the literature on cost-sharing has paid little attention to nurse visits. We employ a staggered difference-in-differences design to examine the effects of adopting a 10-euro copayment for nurse visits on the use of public primary care among Finnish adults. We find that the copayment reduced nurse visits by 9%-10% during a one-year follow-up. There is heterogeneity by income in absolute terms, but not in relative terms. The spillover effects on general practitioner (GP) use are negative but small, with varying statistical significance...
March 2024: Journal of Health Economics
https://read.qxmd.com/read/38388500/recent-innovations-in-long-term-care-coverage-and-financing-a-rapid-scoping-review
#12
JOURNAL ARTICLE
Marilyn Macdonald, Lori E Weeks, Erin Langman, Sheri Roach, Morgan X MacNeil, Julie Caruso, Andrea C Tricco, Ba' Pham, Sharon E Straus, Sujata Mishra, Wanrudee Isaranuwatchai, Gordon V Cormack, Maura R Grossman, Alexa R Yakubovich, Arezoo Mojbafan, Melissa Ignaczak, Caron Leid, Jennifer Watt, Susan Stevens, Tayaba Khan, Janet A Curran, Elaine Moody, Ricardo Rodrigues
OBJECTIVES: To identify, chart and analyse the literature on recent initiatives to improve long-term care (LTC) coverage, financial protection and financial sustainability for persons aged 60 and older. DESIGN: Rapid scoping review. DATA SOURCES: Four databases and four sources of grey literature were searched for reports published between 2017 and 2022. After using a supervised machine learning tool to rank titles and abstracts, two reviewers independently screened sources against inclusion criteria...
February 22, 2024: BMJ Open
https://read.qxmd.com/read/38374959/comparative-costs-to-medicare-and-medicare-beneficiaries-of-alternative-af-stroke-risk-reduction-strategies
#13
JOURNAL ARTICLE
Vivek Y Reddy, Yue Zhong, Alysha M McGovern, Stacey L Amorosi, Meghan B Gavaghan, Deanna S Hertz, Kaywei Low, Scott Freeman, David R Holmes
BACKGROUND: As healthcare costs are increasingly being shifted from payers to patients, it is important to understand the economic consequences of therapeutic strategies to both payers and patients. OBJECTIVE: To determine the relative costs to Medicare and Medicare beneficiaries (patients) of warfarin, non-vitamin K oral anticoagulants (NOACs), and left atrial appendage closure (LAAC) for stroke risk reduction in nonvalvular atrial fibrillation. METHODS: An economic model was developed to assess costs at 5 and 10 years...
2024: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/38374130/reduced-economic-disparity-in-biologics-use-for-psoriasis-after-introducing-the-reducing-copayment-program
#14
JOURNAL ARTICLE
Hyemin Jung, Seong Rae Kim, Soo Ick Cho, Seong Jin Jo
Biologics for psoriasis are efficient and safe, but very expensive. We investigated the association of the reducing copayment program (RCP) with changes in biologics use patterns depending on the income levels of patients with moderate-to-severe psoriasis. This nationwide cohort study included patients identified as having moderate-to-severe psoriasis between 2014 and 2020. Logistic regression models were used to estimate the odds ratio for the use of biologics according to income levels. Among 57,139 patients with moderate-to-severe psoriasis, 3464 (6...
February 20, 2024: Scientific Reports
https://read.qxmd.com/read/38369244/association-of-copayments-with-healthcare-utilization-and-expenditures-among-medicaid-enrollees-with-a-substance-use-disorder
#15
JOURNAL ARTICLE
Antonije Lazic, John M Tilford, Victor P Davis, Clare C Brown
BACKGROUND: The purpose of this study was to examine the association between copayments and healthcare utilization and expenditures among enrollees with substance use disorders. METHODS: This study used claims data (2020-2021) from a private insurer participating in Arkansas's Medicaid expansion. We compared service utilization and expenditures for enrollees in different Medicaid program structures with varying copayments. Enrollees with incomes above 100 % FPL (N = 10,240) had copayments for substance use treatment services while enrollees below 100 % FPL (N = 2478) did not...
February 16, 2024: J Subst Use Addict Treat
https://read.qxmd.com/read/38350249/evaluating-the-effects-of-the-2017-national-health-insurance-coverage-expansion-on-amenable-mortality-and-its-disparities-between-areas-in-south-korea-using-bayesian-structural-time-series-models
#16
JOURNAL ARTICLE
Sang Jun Eun
To improve the low coverage rate of the National Health Insurance (NHI), South Korea implemented the NHI coverage expansion plan in 2017 to cover medically essential non-covered services and reduce copayment rates. This study aimed to estimate the effects of the 2017 NHI coverage expansion on amenable mortality and its disparities between areas in South Korea under a controlled interrupted time-series design using Bayesian structural time-series models. Age-standardized amenable mortality rates and rate differences (RDs) and rate ratios (RRs) between areas for amenable mortality were calculated monthly between July 2012 and December 2021 and used as the response series...
January 7, 2024: Social Science & Medicine
https://read.qxmd.com/read/38334993/association-of-economic-policies-with-hypertension-management-and-control-a-systematic-review
#17
JOURNAL ARTICLE
Donglan Zhang, Jun Soo Lee, Lisa M Pollack, Xiaobei Dong, Joanna M Taliano, Anand Rajan, Nicole L Therrien, Sandra L Jackson, Adebola Popoola, Feijun Luo
IMPORTANCE: Economic policies have the potential to impact management and control of hypertension. OBJECTIVES: To review the evidence on the association between economic policies and hypertension management and control among adults with hypertension in the US. EVIDENCE REVIEW: A search was carried out of PubMed/MEDLINE, Cochrane Library, Embase, PsycINFO, CINAHL, EconLit, Sociological Abstracts, and Scopus from January 1, 2000, through November 1, 2023...
February 2, 2024: JAMA health forum
https://read.qxmd.com/read/38308630/the-impact-of-a-statewide-insulin-copay-cap-policy-for-insured-patients-with-diabetes-in-utah
#18
JOURNAL ARTICLE
Niying Li, Rupesh Panchal, Theodoros Giannouchos, Raymond J Pan, Danielle Nguyen, Robert Nohavec, Laura Britton, Nathorn Chaiyakunapruk, Joseph Biskupiak, Adam Wilson, Diana Brixner
BACKGROUND: Insulin affordability is a huge concern for patients with diabetes in the United States. On March 30, 2020, Utah signed House Bill 207 into law, aimed at capping copayments for insulin at $30 for a 30-day supply. The bill was enacted on January 1, 2021. OBJECTIVE: To assess patient basal insulin adherence, out-of-pocket costs, health plan costs, total costs on insulin, and hemoglobin A1c (A1c) in prepolicy vs postpolicy periods. METHODS: This study is a retrospective analysis using data from a regional health plan in Utah from October 1, 2019, to September 30, 2021...
February 3, 2024: Journal of Managed Care & Specialty Pharmacy
https://read.qxmd.com/read/38263549/characteristics-of-migrant-workers-admitted-from-the-emergency-department
#19
JOURNAL ARTICLE
Jie Er Janice Soo, Joanna Shi-En Chan, Hanis Abdul Kadir, Dennis Wen Jie Chia, Shieh Mei Lai, Sujata Sheth, Marcus Eng Hock Ong, Mui Teng Chua
INTRODUCTION: Emergency department (ED) admissions for non-work-related injuries and illnesses in the migrant worker (MW) population in Singapore are not well studied. We aimed to examine ED triage acuity and bills associated with admissions among MW for non-trauma, workplace injury (WI) trauma, and non-workplace injury (NWI) trauma. METHODS: In this retrospective observational study, we included all work permit holders admitted to hospital via the ED of three public hospitals from 1 May 2016 to 31 October 2016...
January 23, 2024: Singapore Medical Journal
https://read.qxmd.com/read/38262499/getting-what-you-pay-for-impact-of-copayments-on-physical-therapy-and-opioid-initiation-timing-and-continuation-for-newly-diagnosed-low-back-pain
#20
JOURNAL ARTICLE
Michael C Jin, Michael Jensen, Maria Isabel Barros Guinle, Alexander Ren, Zeyi Zhou, Corinna C Zygourakis, Atman M Desai, Anand Veeravagu, John K Ratliff
BACKGROUND CONTEXT: Physical therapy (PT) is an important component of low back pain (LBP) management. Despite established guidelines, heterogeneity in medical management remains common. PURPOSE: We sought to understand how copayments impact timing and utilization of PT in newly diagnosed LBP. STUDY DESIGN/SETTING: The IBM Watson Health MarketScan claims database was utilized in a longitudinal setting. PATIENT SAMPLE: Adult patients with LBP...
January 21, 2024: Spine Journal: Official Journal of the North American Spine Society
keyword
keyword
25314
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.